Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Medtronic announces results from a study into treating chronic migraine

Medtronic announces results from a study into treating chronic migraine

30th June 2008

Medtronic has announced results of a study using its neurostimulation system to stimulate the occipital nerves as a possible way of treating chronic migraines at the meeting of the American Headache Society in Boston.

The study was conducted on patients who regularly experience 15 or more headache days per month and who were unresponsive to conventional therapies.

The Occipital Nerve Stimulation for the Treatment of Intractable Migraine (ONSTIM) collected electronic diary data from 66 patients at nine centres who were observed for three months.

Joel Saper, director of the Michigan Head Pain and Neurological Institute, said: “The ONSTIM results suggest that occipital nerve stimulation, or ONS, may be a promising therapy option for individuals who have not had success in treating their chronic migraine and as a result are living with the painful and often debilitating symptoms.”

Medtronic also announced today that William Hawkins has been named chairman of the board of directors, effective from August 21st.

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.